1c0r: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='1c0r' size='340' side='right'caption='[[1c0r]], [[Resolution|resolution]] 1.00Å' scene=''> | <StructureSection load='1c0r' size='340' side='right'caption='[[1c0r]], [[Resolution|resolution]] 1.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1c0r]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[1c0r]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Amycolatopsis_orientalis Amycolatopsis orientalis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1C0R OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1C0R FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand= | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3FG:(2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC+ACID'>3FG</scene>, <scene name='pdbligand=BGC:BETA-D-GLUCOSE'>BGC</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GHP:(2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC+ACID'>GHP</scene>, <scene name='pdbligand=LAC:LACTIC+ACID'>LAC</scene>, <scene name='pdbligand=MLU:N-METHYL-D-LEUCINE'>MLU</scene>, <scene name='pdbligand=OMY:(BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE'>OMY</scene>, <scene name='pdbligand=OMZ:(BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE'>OMZ</scene>, <scene name='pdbligand=PRD_000204:Vancomycin'>PRD_000204</scene>, <scene name='pdbligand=RER:(1R,3S,4S,5S)-3-AMINO-2,3,6-TRIDEOXY-3-METHYL-ALPHA-L-ARABINO-HEXOPYRANOSE'>RER</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1c0r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1c0r OCA], [https://pdbe.org/1c0r PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1c0r RCSB], [https://www.ebi.ac.uk/pdbsum/1c0r PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1c0r ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1c0r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1c0r OCA], [https://pdbe.org/1c0r PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1c0r RCSB], [https://www.ebi.ac.uk/pdbsum/1c0r PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1c0r ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| Line 22: | Line 20: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Amycolatopsis orientalis]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Axelsen | [[Category: Axelsen PH]] | ||
[[Category: Kaplan | [[Category: Kaplan J]] | ||
[[Category: Loll | [[Category: Loll PJ]] | ||
[[Category: Selinsky | [[Category: Selinsky B]] | ||
Revision as of 11:46, 7 December 2022
COMPLEX OF VANCOMYCIN WITH D-LACTIC ACIDCOMPLEX OF VANCOMYCIN WITH D-LACTIC ACID
Structural highlights
Publication Abstract from PubMedBacterial resistance to vancomycin has been attributed to the loss of an intermolecular hydrogen bond between vancomycin and its peptidoglycan target when cell wall biosynthesis proceeds via depsipeptide intermediates rather than the usual polypeptide intermediates. To investigate the relative importance of this hydrogen bond to vancomycin binding, we have determined crystal structures at 1.0 A resolution for the vancomycin complexes with three ligands that mimic peptides and depsipeptides found in vancomycin-sensitive and vancomycin-resistant bacteria: N-acetylglycine, D-lactic acid, and 2-acetoxy-D-propanoic acid. These, in conjunction with structures that have been reported previously, indicate higher-affinity ligands elicit a structural change in the drug not seen with these low-affinity ligands. They also enable us to define a minimal set of drug-ligand interactions necessary to confer higher-affinity binding on a ligand. Most importantly, these structures point to factors in addition to the loss of an intermolecular hydrogen bond that must be invoked to explain the weaker affinity of vancomycin for depsipeptide ligands. These factors are important considerations for the design of vancomycin analogues to overcome vancomycin resistance. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.,Loll PJ, Kaplan J, Selinsky BS, Axelsen PH J Med Chem. 1999 Nov 4;42(22):4714-9. PMID:10579833[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References |
| ||||||||||||||||